<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2007-05-01" modified="2017-11-22" version="104">
<accession>Q6ZQW0</accession>
<accession>A4UD41</accession>
<accession>F5H5G0</accession>
<name>I23O2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Indoleamine 2,3-dioxygenase 2</fullName>
<shortName>IDO-2</shortName>
<ecNumber evidence="2">1.13.11.-</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Indoleamine 2,3-dioxygenase-like protein 1</fullName>
</alternativeName>
<alternativeName>
<fullName>Indoleamine-pyrrole 2,3-dioxygenase-like protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IDO2</name>
<name type="synonym">INDOL1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Nature" volume="439" first="331" last="335">
<title>DNA sequence and analysis of human chromosome 8.</title>
<authorList>
<person name="Nusbaum C."/>
<person name="Mikkelsen T.S."/>
<person name="Zody M.C."/>
<person name="Asakawa S."/>
<person name="Taudien S."/>
<person name="Garber M."/>
<person name="Kodira C.D."/>
<person name="Schueler M.G."/>
<person name="Shimizu A."/>
<person name="Whittaker C.A."/>
<person name="Chang J.L."/>
<person name="Cuomo C.A."/>
<person name="Dewar K."/>
<person name="FitzGerald M.G."/>
<person name="Yang X."/>
<person name="Allen N.R."/>
<person name="Anderson S."/>
<person name="Asakawa T."/>
<person name="Blechschmidt K."/>
<person name="Bloom T."/>
<person name="Borowsky M.L."/>
<person name="Butler J."/>
<person name="Cook A."/>
<person name="Corum B."/>
<person name="DeArellano K."/>
<person name="DeCaprio D."/>
<person name="Dooley K.T."/>
<person name="Dorris L. III"/>
<person name="Engels R."/>
<person name="Gloeckner G."/>
<person name="Hafez N."/>
<person name="Hagopian D.S."/>
<person name="Hall J.L."/>
<person name="Ishikawa S.K."/>
<person name="Jaffe D.B."/>
<person name="Kamat A."/>
<person name="Kudoh J."/>
<person name="Lehmann R."/>
<person name="Lokitsang T."/>
<person name="Macdonald P."/>
<person name="Major J.E."/>
<person name="Matthews C.D."/>
<person name="Mauceli E."/>
<person name="Menzel U."/>
<person name="Mihalev A.H."/>
<person name="Minoshima S."/>
<person name="Murayama Y."/>
<person name="Naylor J.W."/>
<person name="Nicol R."/>
<person name="Nguyen C."/>
<person name="O'Leary S.B."/>
<person name="O'Neill K."/>
<person name="Parker S.C.J."/>
<person name="Polley A."/>
<person name="Raymond C.K."/>
<person name="Reichwald K."/>
<person name="Rodriguez J."/>
<person name="Sasaki T."/>
<person name="Schilhabel M."/>
<person name="Siddiqui R."/>
<person name="Smith C.L."/>
<person name="Sneddon T.P."/>
<person name="Talamas J.A."/>
<person name="Tenzin P."/>
<person name="Topham K."/>
<person name="Venkataraman V."/>
<person name="Wen G."/>
<person name="Yamazaki S."/>
<person name="Young S.K."/>
<person name="Zeng Q."/>
<person name="Zimmer A.R."/>
<person name="Rosenthal A."/>
<person name="Birren B.W."/>
<person name="Platzer M."/>
<person name="Shimizu N."/>
<person name="Lander E.S."/>
</authorList>
<dbReference type="PubMed" id="16421571"/>
<dbReference type="DOI" id="10.1038/nature04406"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="Gene" volume="396" first="203" last="213">
<title>Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice.</title>
<authorList>
<person name="Ball H.J."/>
<person name="Sanchez-Perez A."/>
<person name="Weiser S."/>
<person name="Austin C.J.D."/>
<person name="Astelbauer F."/>
<person name="Miu J."/>
<person name="McQuillan J.A."/>
<person name="Stocker R."/>
<person name="Jermiin L.S."/>
<person name="Hunt N.H."/>
</authorList>
<dbReference type="PubMed" id="17499941"/>
<dbReference type="DOI" id="10.1016/j.gene.2007.04.010"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] OF 13-420 (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="7082" last="7087">
<title>Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan.</title>
<authorList>
<person name="Metz R."/>
<person name="Duhadaway J.B."/>
<person name="Kamasani U."/>
<person name="Laury-Kleintop L."/>
<person name="Muller A.J."/>
<person name="Prendergast G.C."/>
</authorList>
<dbReference type="PubMed" id="17671174"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-07-1872"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ALTERNATIVE SPLICING</scope>
<scope>ENZYME REGULATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS TRP-248 AND 359-TYR--GLY-420 DEL</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2009" name="Cancer Immunol. Immunother." volume="58" first="153" last="157">
<title>IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism.</title>
<authorList>
<person name="Loeb S."/>
<person name="Koenigsrainer A."/>
<person name="Zieker D."/>
<person name="Bruecher B.L."/>
<person name="Rammensee H.G."/>
<person name="Opelz G."/>
<person name="Terness P."/>
</authorList>
<dbReference type="PubMed" id="18418598"/>
<dbReference type="DOI" id="10.1007/s00262-008-0513-6"/>
</citation>
<scope>MISCELLANEOUS</scope>
<scope>DIFFERENCE BETWEEN IDO1 AND IDO2</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2014" name="Exp. Mol. Med." volume="46" first="E121" last="E121">
<title>Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2.</title>
<authorList>
<person name="Lee Y.K."/>
<person name="Lee H.B."/>
<person name="Shin D.M."/>
<person name="Kang M.J."/>
<person name="Yi E.C."/>
<person name="Noh S."/>
<person name="Lee J."/>
<person name="Lee C."/>
<person name="Min C.K."/>
<person name="Choi E.Y."/>
</authorList>
<dbReference type="PubMed" id="25394548"/>
<dbReference type="DOI" id="10.1038/emm.2014.69"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>DIFFERENCE BETWEEN IDO1 AND IDO2</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2015" name="FEBS J." volume="282" first="2735" last="2745">
<title>Low efficiency IDO2 enzymes are conserved in lower vertebrates, whereas higher efficiency IDO1 enzymes are dispensable.</title>
<authorList>
<person name="Yuasa H.J."/>
<person name="Mizuno K."/>
<person name="Ball H.J."/>
</authorList>
<dbReference type="PubMed" id="25950090"/>
<dbReference type="DOI" id="10.1111/febs.13316"/>
</citation>
<scope>DIFFERENCE BETWEEN IDO1 AND IDO2</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2014" name="Front. Immunol." volume="5" first="585" last="585">
<title>IDO2 in immunomodulation and autoimmune disease.</title>
<authorList>
<person name="Prendergast G.C."/>
<person name="Metz R."/>
<person name="Muller A.J."/>
<person name="Merlo L.M."/>
<person name="Mandik-Nayak L."/>
</authorList>
<dbReference type="PubMed" id="25477879"/>
<dbReference type="DOI" id="10.3389/fimmu.2014.00585"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2015" name="Front. Immunol." volume="6" first="34" last="34">
<title>Tryptophan-degrading enzymes in tumoral immune resistance.</title>
<authorList>
<person name="van Baren N."/>
<person name="Van den Eynde B.J."/>
</authorList>
<dbReference type="PubMed" id="25691885"/>
<dbReference type="DOI" id="10.3389/fimmu.2015.00034"/>
</citation>
<scope>REVIEW</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<comment type="function">
<text evidence="2 10">Catalyzes the first and rate limiting step of the catabolism of the essential amino acid tryptophan along the kynurenine pathway (PubMed:17671174). Involved in immune regulation. May not play a significant role in tryptophan-related tumoral resistance (PubMed:25691885).</text>
</comment>
<comment type="catalytic activity">
<text evidence="2">L-tryptophan + O(2) = N-formyl-L-kynurenine.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="1">
<name>heme</name>
<dbReference type="ChEBI" id="CHEBI:30413"/>
</cofactor>
<text evidence="1">Binds 1 heme group per subunit.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="2">Activity is inhibited by D-1MT (1-methyl-D-tryptophan) and MTH-trp (methylthiohydantoin-DL-tryptophan) but not L-1MT (1-methyl-L-tryptophan).</text>
</comment>
<comment type="pathway">
<text>Amino-acid degradation; L-tryptophan degradation via kynurenine pathway; L-kynurenine from L-tryptophan: step 1/2.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q6ZQW0-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q6ZQW0-2</id>
<name>2</name>
<sequence type="described" ref="VSP_024858 VSP_024859"/>
</isoform>
<text evidence="2 9">Additional isoforms exist at least in placenta and brain.</text>
</comment>
<comment type="tissue specificity">
<text evidence="2 10">Detected in liver, small intestine, spleen, placenta, thymus, lung, brain, kidney, and colon (PubMed:17671174). Also expressed at low level in testis and thyroid. Not expressed in the majority of human tumor samples (>99%) (PubMed:25691885).</text>
</comment>
<comment type="polymorphism">
<text evidence="2 8">The variant Trp-248 (p.R248W) drastically reduces the enzymatic activity (PubMed:17671174, PubMed:18418598). The Del359-420 variant (p.Y359X) generates a truncated, enzymatically inactive protein (PubMed:17671174). The high prevalence of these polymorphic alleles results in a non-functional IDO2 enzyme in up to 50% of Caucasians (PubMed:18418598).</text>
</comment>
<comment type="miscellaneous">
<text evidence="3 4 5">IDO1 and IDO2 are 2 distinct enzymes which catalyze the same reaction. IDO2 affinity for tryptophan is much lower than that of IDO1. 50 % of Caucasians harbor polymorphisms which abolish IDO2 enzymatic activity. IDO2 is expressed in human tumors in an inactive form: tryptophan degradation is entirely provided by IDO1 in these cells (PubMed:18418598). IDO2 may play a role as a negative regulator of IDO1 by competing for heme-binding with IDO1 (PubMed:25394548). Low efficiency IDO2 enzymes have been conserved throughout vertebrate evolution, whereas higher efficiency IDO1 enzymes are dispensable in many lower vertebrate lineages (PubMed:25950090). IDO1 may have arisen by gene duplication of a more ancient proto-IDO gene before the divergence of marsupial and eutherian (placental) mammals.</text>
</comment>
<comment type="similarity">
<text evidence="11">Belongs to the indoleamine 2,3-dioxygenase family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/IDO2ID44387ch8p11.html"/>
</comment>
<dbReference type="EC" id="1.13.11.-" evidence="2"/>
<dbReference type="EMBL" id="EF052681">
<property type="protein sequence ID" value="ABM69260.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK128691">
<property type="protein sequence ID" value="BAC87573.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007991">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC087518">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113496">
<property type="protein sequence ID" value="AAI13497.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113498">
<property type="protein sequence ID" value="AAI13499.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6114.2">
<molecule id="Q6ZQW0-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_919270.2">
<molecule id="Q6ZQW0-1"/>
<property type="nucleotide sequence ID" value="NM_194294.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.676257"/>
<dbReference type="ProteinModelPortal" id="Q6ZQW0"/>
<dbReference type="SMR" id="Q6ZQW0"/>
<dbReference type="BioGrid" id="127980">
<property type="interactions" value="9"/>
</dbReference>
<dbReference type="IntAct" id="Q6ZQW0">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000443432"/>
<dbReference type="BindingDB" id="Q6ZQW0"/>
<dbReference type="ChEMBL" id="CHEMBL3627587"/>
<dbReference type="iPTMnet" id="Q6ZQW0"/>
<dbReference type="PhosphoSitePlus" id="Q6ZQW0"/>
<dbReference type="BioMuta" id="IDO2"/>
<dbReference type="DMDM" id="215274147"/>
<dbReference type="PaxDb" id="Q6ZQW0"/>
<dbReference type="PeptideAtlas" id="Q6ZQW0"/>
<dbReference type="PRIDE" id="Q6ZQW0"/>
<dbReference type="DNASU" id="169355"/>
<dbReference type="Ensembl" id="ENST00000502986">
<molecule id="Q6ZQW0-1"/>
<property type="protein sequence ID" value="ENSP00000443432"/>
<property type="gene ID" value="ENSG00000188676"/>
</dbReference>
<dbReference type="GeneID" id="169355"/>
<dbReference type="KEGG" id="hsa:169355"/>
<dbReference type="UCSC" id="uc010lwy.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="UCSC" id="uc064mgi.1">
<molecule id="Q6ZQW0-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="169355"/>
<dbReference type="DisGeNET" id="169355"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000188676.13"/>
<dbReference type="GeneCards" id="IDO2"/>
<dbReference type="H-InvDB" id="HIX0007468"/>
<dbReference type="HGNC" id="HGNC:27269">
<property type="gene designation" value="IDO2"/>
</dbReference>
<dbReference type="MIM" id="612129">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q6ZQW0"/>
<dbReference type="OpenTargets" id="ENSG00000188676"/>
<dbReference type="PharmGKB" id="PA164720782"/>
<dbReference type="eggNOG" id="ENOG410IGEY">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XQHE">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000002154"/>
<dbReference type="HOGENOM" id="HOG000190192"/>
<dbReference type="InParanoid" id="Q6ZQW0"/>
<dbReference type="KO" id="K00463"/>
<dbReference type="OMA" id="GQMHDYV"/>
<dbReference type="OrthoDB" id="EOG091G0DCU"/>
<dbReference type="PhylomeDB" id="Q6ZQW0"/>
<dbReference type="TreeFam" id="TF330978"/>
<dbReference type="BRENDA" id="1.13.11.52">
<property type="organism ID" value="2681"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-71240">
<property type="pathway name" value="Tryptophan catabolism"/>
</dbReference>
<dbReference type="UniPathway" id="UPA00333">
<property type="reaction ID" value="UER00453"/>
</dbReference>
<dbReference type="ChiTaRS" id="IDO2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GenomeRNAi" id="169355"/>
<dbReference type="PRO" id="PR:Q6ZQW0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 8"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000188676"/>
<dbReference type="ExpressionAtlas" id="Q6ZQW0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0020037">
<property type="term" value="F:heme binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0033754">
<property type="term" value="F:indoleamine 2,3-dioxygenase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004833">
<property type="term" value="F:tryptophan 2,3-dioxygenase activity"/>
<property type="evidence" value="ECO:0000269"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0002376">
<property type="term" value="P:immune system process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006569">
<property type="term" value="P:tryptophan catabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0019441">
<property type="term" value="P:tryptophan catabolic process to kynurenine"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="InterPro" id="IPR000898">
<property type="entry name" value="Indolamine_dOase"/>
</dbReference>
<dbReference type="InterPro" id="IPR037217">
<property type="entry name" value="Trp/Indoleamine_2_3_dOase-like"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR28657">
<property type="entry name" value="PTHR28657"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01231">
<property type="entry name" value="IDO"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF140959">
<property type="entry name" value="SSF140959"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0223">Dioxygenase</keyword>
<keyword id="KW-0349">Heme</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0560">Oxidoreductase</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0823">Tryptophan catabolism</keyword>
<feature type="chain" description="Indoleamine 2,3-dioxygenase 2" id="PRO_0000285262">
<location>
<begin position="1"/>
<end position="420"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron (heme proximal ligand)" evidence="1">
<location>
<position position="360"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_024858" evidence="6 7">
<original>FLEIGNLETIISFP</original>
<variation>DGVSLCLPGWSAVA</variation>
<location>
<begin position="159"/>
<end position="172"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_024859" evidence="6 7">
<location>
<begin position="173"/>
<end position="420"/>
</location>
</feature>
<feature type="sequence variant" description="Decreased indoleamine 2,3-dioxygenase activity; dbSNP:rs10109853." id="VAR_032007" evidence="2">
<original>R</original>
<variation>W</variation>
<location>
<position position="248"/>
</location>
</feature>
<feature type="sequence variant" description="Loss of indoleamine 2,3-dioxygenase activity." id="VAR_073727" evidence="2">
<location>
<begin position="359"/>
<end position="420"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; ABM69260." ref="1" evidence="11">
<location>
<begin position="1"/>
<end position="13"/>
</location>
</feature>
<evidence key="1" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P14902"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17671174"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18418598"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25394548"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25950090"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="18418598"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25477879"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="25691885"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000305"/>
<sequence length="420" mass="47075" checksum="28C0CDCD10F933C4" modified="2015-10-14" version="4">
MLHFHYYDTSNKIMEPHRPNVKTAVPLSLESYHISEEYGFLLPDSLKELPDHYRPWMEIA
NKLPQLIDAHQLQAHVDKMPLLSCQFLKGHREQRLAHLVLSFLTMGYVWQEGEAQPAEVL
PRNLALPFVEVSRNLGLPPILVHSDLVLTNWTKKDPDGFLEIGNLETIISFPGGESLHGF
ILVTALVEKEAVPGIKALVQATNAILQPNQEALLQALQRLRLSIQDITKTLGQMHDYVDP
DIFYAGIRIFLSGWKDNPAMPAGLMYEGVSQEPLKYSGGSAAQSTVLHAFDEFLGIRHSK
ESGDFLYRMRDYMPPSHKAFIEDIHSAPSLRDYILSSGQDHLLTAYNQCVQALAELRSYH
ITMVTKYLITAAAKAKHGKPNHLPGPPQALKDRGTGGTAVMSFLKSVRDKTLESILHPRG
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>